Oberman Law Firm

OBERMAN LAW FIRM

updates

Page Under Construction.

We Never Stop Improving – Reinventing Client Services
01Dec

We Never Stop Improving – Reinventing Client Services

We consistently review ways to improve the client experience. A Bold Approach Our ambitions are bold, but so are our clients’ ambitions. We will always value long-term partnerships over short-term gains. Success never happens overnight. Through our non-stop evaluation of…

Oberman Law Firm Launches Psychedelics and Emerging Therapies Practice Group
29Nov

Oberman Law Firm Launches Psychedelics and Emerging Therapies Practice Group

Oberman Law Firm is pleased to announce the launch of its Psychedelics and Emerging Therapies Practice Group, which is an interdisciplinary, cross-office group of attorneys capable of addressing the challenges that innovators research in order to develop and commercialize of…

Senate Banking Committee Advances Marijuana Financing Bill
16Nov

Senate Banking Committee Advances Marijuana Financing Bill

The legislation (the Secure and Fair Enforcement Regulation Banking, or SAFER, Banking Act) would allow legal marijuana businesses to use major financial and banking institutions for financing. Under current federal law, banks and creditors can be federally prosecuted for providing…

Cannabis Update: Change Could Be Coming to Georgia
15Nov

Cannabis Update: Change Could Be Coming to Georgia

Legislation is currently pending that would legalize and regulate the use, possession, and retail sale of marijuana in Georgia. Three (3) bills are currently pending [SB263, SR165 and HR281]. The first would regulate the sale of marijuana and its commercial…

Oberman Law Firm Launches Cannabis Practice Group
14Nov

Oberman Law Firm Launches Cannabis Practice Group

Oberman Law Firm is pleased to announce the launching of its Cannabis Practice Group, which will provide corporate, transactional and regulatory guidance to start-ups, operators, private equity and multi-national companies in one of the nation’s fastest growing and complex industries.…

Compounding Ketamine – FDA Issues New Warning
13Nov

Compounding Ketamine – FDA Issues New Warning

On October 10, 2023, the U.S. Food and Drug Administration (FDA) issued a public warning regarding the potential health risks associated with compounding ketamine products. This particular warning follows an FDA alert issued on February 16, 2022, regarding the potential…

MORE RESOURCES

Sharing our knowledge and expertise.